Literature DB >> 12046723

Itraconazole- and fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study.

N Somchit1, S M Hassim, S H Samsudin.   

Abstract

This current study was to investigate the in vitro cytotoxicity of rat hepatocytes induced by the antifungal drugs, itraconazole and fluconazole. Both antifungal drugs caused dose-dependent cytotoxicity. In vitro incubation of hepatocytes with itraconazole revealed significantly higher lactate dehydrogenase (LDH) leakage when compared to fluconazole. Phenobarbital pretreated hepatocytes contained significantly higher total cytochrome P450 content than the control hepatocytes. P450 content was reduced approximately 30% for both types of hepatocytes after 6 hours incubation. Interestingly, cytotoxicity of itraconazole was reduced significantly by phenobarbital pretreatment. Phenobarbital did not have any effect on the cytotoxicity induced by fluconazole. These results demonstrate the in vitro toxicity of hepatocytes induced by itraconazole and fluconazole that were expressed in a dose- and time-dependent manner. Phenobarbital plays a role in the cytoprotection of hepatocytes to itraconazole-induced but not fluconazole-induced cytotoxicity in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046723     DOI: 10.1191/0960327102ht208oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Mefenamic Acid induced nephrotoxicity: an animal model.

Authors:  Muhammad Nazrul Somchit; Faizah Sanat; Gan Eng Hui; Shahrin Iskandar Wahab; Zuraini Ahmad
Journal:  Adv Pharm Bull       Date:  2014-08-10

2.  Effects of cytochrome p450 inhibitors on itraconazole and fluconazole induced cytotoxicity in hepatocytes.

Authors:  Nhareet Somchit; Chong Sock Ngee; Azhar Yaakob; Zuraini Ahmad; Zainul Amiruddin Zakaria
Journal:  J Toxicol       Date:  2009-07-16

3.  Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent.

Authors:  Mohd Zobir Hussein; Samer Hasan Al Ali; Zulkarnain Zainal; Muhammad Nazrul Hakim
Journal:  Int J Nanomedicine       Date:  2011-07-04

4.  Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.

Authors:  Ronan J Kelly; Amir M Ansari; Tomoharu Miyashita; Marianna Zahurak; Frank Lay; A Karim Ahmed; Louis J Born; Maryam K Pezhouh; Kevan J Salimian; Christopher Ng; Aerielle E Matsangos; Anne-Heloise Stricker-Krongrad; Ken-Ichi Mukaisho; Guy P Marti; Christine H Chung; Marcia I Canto; Michelle A Rudek; Stephen J Meltzer; John W Harmon
Journal:  Ann Surg       Date:  2021-06-01       Impact factor: 13.787

5.  Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats.

Authors:  Star Khoza; Ishmael Moyo; Denver Ncube
Journal:  J Toxicol       Date:  2017-02-05

6.  Cytotoxic and Genotoxic Effects of Fluconazole on African Green Monkey Kidney (Vero) Cell Line.

Authors:  Regianne Maciel Dos Santos Correa; Tatiane Cristina Mota; Adriana Costa Guimarães; Laís Teixeira Bonfim; Rommel Rodriguez Burbano; Marcelo de Oliveira Bahia
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

7.  Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.

Authors:  Michela Cantiello; Monica Carletti; Mery Giantin; Giulia Gardini; Francesca Capolongo; Paolo Cascio; Marianna Pauletto; Flavia Girolami; Mauro Dacasto; Carlo Nebbia
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.